Atsena Therapeutics

Developer of gene therapies for the treatment of ocular diseases

placeDurham, North Carolina, United States calendar_todayFounded 2020 groups23 employees language atsenatx.com

Registered entities

Social engagement

Social engagement: 13.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Hatteras Venture Partners, Foundation Fighting Blindness, Sofinnova Investments, Bain Capital Life Sciences.

Investor typeCountShare
Venture capital758%
Other / undisclosed542%

Hiring activity

Hires occasionally

4 roles tracked across 2 of the last 12 months

10 Jun 2026 · Senior Manager, Quality Operations · Durham

10 Jun 2026 · Director, Regulatory Strategy · Durham

5 Oct 2025 · Vice President of Medical Affairs · Durham

7 Sep 2025 · Associate Director Clinical Development · Durham

6 Sep 2025 · Associate Director Clinical Development ( {{city}}) · Durham

Based on job postings tracked across public sources.

Recent activity

22 Jun 2026
Milestone
regulatory
18 Jun 2026
Event
BIO 2026
9 Jun 2026
Event
Fundamental Fighting Blindness United in Vision 2026 conference
Coming soon